AdipoGen Life Sciences

anti-IgG1 (human mAb (Biotin)

Product Code:
 
AG-29B-0007B
Product Group:
 
Secondary Antibody
Antibody Clonality:
 
Secondary Antibody
Regulatory Status:
 
RUO
Target Species:
 
Human
Applications:
  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Fluorescence-activated cell sorting (FACS)
  • Western Blot (WB)
Shipping:
 
-20°C
Storage:
 
+4°C
 

No additional charges, what you see is what you pay! *

CodeSizePrice
AG-29B-0007B-C05050 ug£180.00
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: Switzerland.
Typical lead time: 7-10 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Concentration:
1mg/ml.
EClass:
32160000
Form (Short):
liquid
Formulation:
Liquid. In PBS (sterile) containing 0.1% sodium azide.
Handling Advice:
After opening, prepare aliquots and store at -20°C.Avoid freeze/thaw cycles.
Immunogen:
Human IgG1 Fc-BAFF recombinant protein
Labels - Conjugates:
Biotin
Long Description:
Monoclonal Antibody. Recognizes human IgG1:Fc. Isotype: Mouse IgG1. Clone: Huf 5.4. Applications: ELISA, FACS, WB. Liquid. In PBS (sterile) containing 0.1% sodium azide. Detects human IgG1:Fc proteins and can be used as a secondary control antibody.
Package Type:
Plastic Vial
Product Description:
Detects human IgG1:Fc proteins and can be used as a secondary control antibody.
Purity:
>95% (SDS-PAGE)
Source / Host:
Purified from concentrated hybridoma tissue culture supernatant.
Specificity:
Recognizes human IgG1:Fc.
Transportation:
Non-hazardous
UNSPSC Category:
Secondary Antibody Conjugates
UNSPSC Number:
12352203
Use & Stability:
Stable for at least 1 year after receipt when stored at -20°C.

References

Rescue of the mature B cell compartment in BAFF-deficient mice by treatment with recombinant Fc-BAFF: L.K. Swee, et al.; Immunol. Lett. 131, 40 (2010)